Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Nova Diabetes Care Recalls of Several Lots of Nova Max Glucose Test Strips
Nova Diabetes Care is voluntarily recalling and replacing several lots of Nova Max Glucose Test Strips and unused Nova Max Plus Glucose Meter Kits. The Nova Max Test Strip lot numbers listed below have been recalled because some of the blood glucose test strips may report a false, abnormally high blood glucose result. A false, abnormally high blood glucose result could, under certain conditions, cause an insulin dosing error that could lead to a serious health risk requiring immediate medical attention. Nova Max Test Strip Recalled Lots: 1020211346 1020212291 1020412341 1020211355 1020213043 1020512087 1020212032 1020213074 1020611348 1020212100 1020213109 1020712206 1020212101 1020411347 1020811350 1020212153 1020412255 1020912292 1020212207 Several Nova Max Plus Meter Kits are also being recalled because they contain the recalled test strips. The glucose meters in these kits are not recalled and can be used with Nova Max Glucose Test Strips from a different lot that is not part of this recall. Patients with an unopened Nova Max Plus Meter Kit can find a list of recalled kit lot numbers on the Nova Diabetes Care website. This recall does not affect any other brand of glucose meters or test strips. For more information and to view the list of recalled Nova Max Plus Meter Kit lot numbers, please visit: http://www.novacares.com/news/nova-max-recall.php
Learn More

FDA Strengthens Warnings for Antimalarial Drug Mefloquine For Serious Psychiatric and Nerve Side Effects
The Food and Drug Administration (FDA) has strengthened and updated the prescribing information, the patient Medication Guide, and wallet card of the antimalarial drug mefloquine hydrochloride to include warnings about the neurologic and psychiatric side effects associated with this medicine. The mefloquine prescribing information now contains a boxed warning. A boxed warning is the most serious kind of warning possible about these potential problems. Mefloquinine is a medicine used to prevent and treat malaria, a serious disease caused by a parasite that commonly infects mosquitoes, which then bite humans. Mefloquine was previously marketed under the brand name Lariam. While Lariam product is not currently marketed, generic mefloquine products are available in the U.S. The neurologic side effects from mefloquine can include, but are not limited to dizziness, loss of balance, or ringing in the ears. Neurologic side effects can occur at any time during drug use, and can last for months to years after the drug is stopped or can be permanent. The psychiatric side effects can include feeling anxious, mistrustful, depressed, or having hallucinations. The FDA will continue to evaluate the safety of mefloquine and will communicate with the public again if additional information becomes available. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/ucm362227.htm
Learn More

Date Published Title Drug Source
2013-07-30 Nova Diabetes Care Recalls of Several Lots of Nova Max Glucose Test Strips Tolazamide Manufacturer
2013-07-29 FDA Strengthens Warnings for Antimalarial Drug Mefloquine For Serious Psychiatric and Nerve Side Effects Mefloquine FDA
2013-07-29 FDA Warns: Healthy Life Chemistry By Purity First B-50 Contains Possibly Harmful Anabolic Steroids Vitamin B Complex FDA
2013-07-29 FDA Places Strict Limits on Oral Ketoconazole (Nizoral) Use Ketoconazole FDA
2013-07-08 Sandoz Announces Voluntary Recall of One Lot of Estarylla Ethinylestradiol with Norgestimate FDA
2013-07-03 FDA Updates Prescribing Information for Blood Pressure Medicine Olmesartan to Include Link to Intestinal Problems (Sprue-Like Enteropathy) Hydrochlorothiazide, Amlodipine, and Olmesartan FDA
2013-06-20 One Lot of Rugby Labeled Enteric Coated Aspirin 81 mg Tablets Recalled - May Contain Acetaminophen 500 mg Tablets Aspirin FDA
2013-06-19 FDA Investigates Reports of Two Deaths Following Injections of Zyprexa Relprevv (Olanzapine Pamoate) Olanzapine FDA
2013-06-13 Zydus Pharmaceuticals Recalls One Lot of Warfarin 2 mg Tablets Warfarin FDA
2013-06-10 Nephron Pharmaceuticals Corporation Recalls EZ Breathe Atomizer Ipratropium FDA
2013-06-10 Nephron Pharmaceuticals Corporation Recalls EZ Breathe Atomizer and Asthmanefrin Starter Kit FDA
2013-05-29 The Last of the CFC-Containing Inhalers To Be Taken Off the Market Maxair FDA
2013-05-29 L. Perrigo Co. Recalls Select Lots of Liothyronine Sodium Tablets, 5 mcg Liothyronine FDA
2013-05-24 Physicians Total Care Recalls Single Lot of Plavix 75 mg Clopidogrel FDA
2013-05-24 Recall of Levoxyl Produces Medication Shortage Levothyroxine Manufacturer
2013-05-07 FDA Warns Pregnant Women to Not Use Certain Migraine Prevention Medicines Divalproex Sodium FDA
2013-05-01 FDA Updates Prescribing Information for Samsca: Limits Use Tolvaptan FDA
2013-04-29 Anti-Seizure Medicine Potiga (Ezogabine) Linked to Eye Problems and Blue Skin Discoloration Ezogabine FDA
2013-04-26 Saratoga Therapeutics, LLC Recalls ebA Multivitamin Supplement Due to Undeclared Milk Components Multivitamin FDA
2013-04-19 One Touch Verio IQ and FreeStyle lnsulinx Blood Glucose Meters Recalled Insulin Lispro and Insulin Lispro Protamine FDA